JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
出版年份 2012 全文链接
标题
JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
作者
关键词
-
出版物
ARTHRITIS AND RHEUMATISM
Volume 64, Issue 9, Pages 3006-3015
出版商
Wiley
发表日期
2012-05-02
DOI
10.1002/art.34500
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The transcription factor JunD mediates transforming growth factor -induced fibroblast activation and fibrosis in systemic sclerosis
- (2011) K. Palumbo et al. ANNALS OF THE RHEUMATIC DISEASES
- Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
- (2011) C. Dees et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis
- (2011) Clara Dees et al. ARTHRITIS AND RHEUMATISM
- Platelet-derived serotonin links vascular disease and tissue fibrosis
- (2011) Clara Dees et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia
- (2011) Ryan C Russell et al. NATURE MEDICINE
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
- (2010) A. J. Tyndall et al. ANNALS OF THE RHEUMATIC DISEASES
- Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
- (2010) Sieglinde Marquart et al. ARTHRITIS AND RHEUMATISM
- Animal models of systemic sclerosis: Prospects and limitations
- (2010) Christian Beyer et al. ARTHRITIS AND RHEUMATISM
- JAK2 inhibitors: What's the true therapeutic potential?
- (2010) Fabio P.S. Santos et al. BLOOD REVIEWS
- A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
- (2010) Maoyin Pang et al. KIDNEY INTERNATIONAL
- Inhibition of JAK–STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells
- (2010) T Lasho et al. LEUKEMIA
- JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
- (2010) A Pardanani et al. LEUKEMIA
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
- (2009) Y. Wang et al. BLOOD
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic potential of JAK2 inhibitors
- (2009) S. Verstovsek Hematology-American Society of Hematology Education Program
- Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts
- (2008) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Suppressor of cytokine signaling-1 reduces high glucose-induced TGF-β1 and fibronectin synthesis in human mesangial cells
- (2008) Yonghong Shi et al. FEBS LETTERS
- Pulmonary rehabilitation in idiopathic pulmonary fibrosis: A call for continued investigation
- (2008) Jeffrey J. Swigris et al. RESPIRATORY MEDICINE
- Review: Therapies for interstitial lung disease: past, present and future
- (2008) Robert Kim et al. Therapeutic Advances in Respiratory Disease
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started